Conference Calls & Webcasts

Latest Webcast

07/28/2014 - Conference Call: Q2 2014 Results

MorphoSys AG published its first six months’ 2014 results on 28 July 2014.
At 2:00 pm CEST (1:00 pm BST, 8:00 am EDT), the Management Board of MorphoSys AG hosted a public conference call to present MorphoSys’s financial results for the first six months of 2014 and provided further details on the Company’s latest developments.

A manuscript of the conference will be available on this website in due course.

 

Archive

03/05/2013 - Year End 2012 and Q4 Results

MorphoSys published its Annual Financial Results 2012 on March 5, 2013. In conjunction with that, the Company held a conference call to further discuss the financial and operational results.

Go to Replay of Webcast

01/10/2013 - Webcast: J.P. Morgan Healthcare Conference

Dr. Simon Moroney, CEO of MorphoSys AG, presented the Company at the J.P. Morgan Healthcare Conference in San Francisco, USA, on Thursday, January 10, 2013.

 Go to Webcast...

Conference Call and Webcast: Bio-Rad plans Acquisition of MorphoSys’s Research and Diagnostic Antibody Business AbD Serotec

On December 17, 2012 the Management Board of MorphoSys AG hosted a public conference call and webcast to present information on Bio-Rad’s planned Acquisition of MorphoSys’s Research and Diagnostic Antibody Business AbD Serotec.

11/15/2012 - Webcast: Jefferies Global Healthcare Conference

Jens Holstein, CFO of MorphoSys AG, will present the Company at the Jefferies Global Healthcare Conference in London, UK, on November 15, 2012 at 2:20 pm GMT (9:20 am EST, 3:20 pm CET).

 

11/07/2012 - Conference Call and Webcast: Q3 2012 Results

MorphoSys AG published its first nine months’ 2012 results on November 7, 2012.

During a public conference call and webcast, the Management Board of MorphoSys AG presented MorphoSys’s financial results for the first nine months of 2012 and provided further details on the Company’s latest developments.

09/21/2012 - Conference Call and Webcast: Clinical Trial Results of MOR103 in Rheumatoid Arthritis

On September 21, 2012, the Management Board of MorphoSys AG hosted a public conference call and webcast to present information on the results of the clinical phase 1b/2a trial of MorphoSys's proprietary antibody MOR103 in patients with rheumatoid arthritis, which was announced the day before.

08/02/2012 - Conference Call and Webcast: Q2 2012 Results

MorphoSys published its first six months’ 2012 results on August 2, 2012.

During a public conference call and webcast, the Management Board of MorphoSys AG presented MorphoSys’s financial results for the first six months of 2012 and provided further details on the Company’s latest developments.

06/07/2012 - Webcast: Jefferies 2012 Global Healthcare Conference

Dr. Simon Moroney, CEO of MorphoSys AG, will present the Company at the Jefferies 2012 Global Healthcare Conference in New York, USA, on Thursday, June 07, 2012 at 01:00 pm EDT (07:00 pm CEST, 06:00 pm BST).

05/07/2012 - Webcast: Deutsche Bank 37th Annual Healthcare Conference

Dr. Simon Moroney, CEO of MorphoSys AG, will present the Company at the Deutsche Bank 37th Annual Healthcare Conference in Boston, USA, on Monday, May 07, 2012 at 10:00 am EDT (04:00 pm CEST, 03:00 pm BST).

Go to Webcast...

12/05/04 - Conference Call and Webcast: Q1 2012 Results

MorphoSys AG published its first three months’ 2012 results on May 04, 2012.
In a public conference call and webcast, the Management Board of MorphoSys AG presented MorphoSys’s financial results for the first three months of 2012 and provided further details on the Company’s latest developments.